[Frontiers in Bioscience 3, d781 -794, August 1, 1998]
Reprints
PubMed
CAVEAT LECTOR




Table of Conents
 Previous Section   Next Section

FGF SIGNALING IN SKELETAL DEVELOPMENT

Michael C. Naski and David M. Ornitz

Department of Molecular Biology and Pharmacology, Washington University School of Medicine, Campus Box 8103, 660 S. Euclid Ave., St. Louis, MO 63110

Received12/22/98 Accepted 2/17/98

8. REFERENCES

1. Basilico, C. & D. Moscatelli: The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165 (1992)

2. Klagsbrun, M.: The fibroblast growth factor family: structural and biological properties. Prog. Growth Fact. Res. 1, 207-235 (1989)

3. Tanaka, A., K. Miyamoto, N. Minamino, M. Takeda, B. Sato, M. H. & K. Matsumoto: Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA. 89, 8928-8932 (1992)

4. Miyamoto, M., K. Naruo, C. Seko, S. Matsumoto, T. Kondo & T. Kurokawa: Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell. Biol. 13, 4251-4259 (1993)

5. Smallwood, P. M., I. Munozsanjuan, P. Tong, J. P. Macke, S. H. C. Hendry, D. J. Gilbert, N. G. Copeland, N. A. Jenkins & J. Nathans: Fibroblast growth factor (FGF) homologous factors - new members of the FGF family implicated in nervous system Development Proc. Natl. Acad. Sci. USA. 93, 9850-9857 (1996)

6. Skaer, H.: Morphogenesis: FGF branches out. Curr. Biol. 7, R238-241 (1997)

7. Mansour, S., J. Goddard & M. Capecchi: Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development 117, 13-28 (1993)

8. Guo, L., L. Degenstein & E. Fuchs: Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10, 165-175 (1996)

9. Hébert, J. M., T. Rosenquist, J. Götz & G. R. Martin: FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell. 78, 1017-1025 (1994)

10. Feldman, B., W. Poueymirou, V. E. Papaioannou, T. M. DeChiara & M. Goldfarb: Requirement of FGF-4 for postimplantation mouse Development Science 267, 246-249 (1995)

11. Kato, Y. & M. Iwamoto: Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem. 265, 5903-5909 (1990)

12. Nagai, H., R. Tsukuda & H. Mayahara: Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone. 16, 367-73 (1995)

13. Nakamura, T., K. Hanada, M. Tamura, T. Shibanushi, H. Nigi, M. Tagawa, S. Fukumoto & T. Matsumoto: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136, 1276-84 (1995)

14. Lee, P. L., D. E. Johnson, L. S. Cousens, V. A. Fried & L. T. Williams: Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245, 57-60 (1989)

15. Dionne, C. A., G. Crumley, F. Bellot, J. M. Kaplow, G. Searfoss, M. Ruta, W. H. Burgess, M. Jaye & J. Schlessinger: Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692 (1990)

16. Ruta, M., W. Burgess, D. Givol, J. Epstein, N. Neiger, J. Kaplow, G. Crumley, C. Dionne, M. Jaye & J. Schlessinger: Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc. Natl. Acad. Sci. USA. 86, 8722-8726 (1989)

17. Reid, H. H., A. F. Wilks & O. Bernard: Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc. Natl. Acad. Sci. USA. 87, 1596-1600 (1990)

18. Hattori, Y., H. Odagiri, H. Nakatani, K. Miyagawa, K. Naito, H. Sakamoto, O. Katoh, T. Yoshida, T. Sugimura & M. Terada: K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA. 87, 5983-5987 (1990)

19. Safran, A., A. Avivi, A. Orr-Urtereger, G. Neufeld, P. Lonai, D. Givol & Y. Yarden: The murine flg gene encodes a receptor for fibroblast growth factor. Oncogene 5, 635-643 (1990)

20. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder & D. M. Ornitz: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64, 841-848 (1991)

21. Partanen, J., T. P. Makela, E. Eerola, J. Korhonen, H. Hirvonen, L. Claesson-Welsh & K. Alitalo: FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347-1354 (1991)

22. Ornitz, D. M., J. Xu, J. S. Colvin, D. G. McEwen, C. A. MacArthur, F. Coulier, G. Gao & M. Goldfarb: Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297 (1996)

23. Chellaiah, A. T., D. G. McEwen, S. Werner, J. Xu & D. M. Ornitz: Fibroblast growth factor receptor (FGFR) 3: Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem. 269, 11620-11627 (1994)

24. Werner, S., D.-S. R. Duan, C. de Vries, K. G. Peters, D. E. Johnson & L. T. Williams: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol. Cell. Biol. 12, 82-88 (1992)

25. Miki, T., D. P. Bottaro, T. P. Fleming, C. L. Smith, W. H. Burgess, A. M.-L. Chan & S. A. Aaronson: Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA. 89, 246-250 (1992)

26. Xu, X., M. Weinstein, C. Li, M. Naski, R. I. Cohen, D. M. Ornitz, P. Leder & C. Deng: Fibroblast growth factor receptor 2 (FGFR2) is required for placentation and limb bud induction. Development (in press)

27. Noji, S., E. Koyama, F. Myokai, T. Nohno, H. Ohuchi, K. Nishikawa & S. Taniguchi: Differential expression of three chick FGF receptor genes, FGFR1, FGFR2 and FGFR3, in limb and feather Development Progr in Clin Biol Res 383B, 645-54 (1993)

28. Ornitz, D. M., A. Yayon, J. G. Flanagan, C. M. Svahn, E. Levi & P. Leder: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247 (1992)

29. Rapraeger, A. C., A. Krufka & B. B. Olwin: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708 (1991)

30. Johnson, D. E. & L. T. Williams: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41 (1993)

31. Johnson, D. E., J. Lu, H. Chen, S. Werner & L. T. Williams: The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627-4634 (1991)

32. Shi, E., M. Kan, J. Xu, F. Wang, J. Hou & W. L. McKeehan: Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol. Cell. Biol. 13, 3907-18 (1993)

33. Champion-Arnaud, P., C. Ronsin, E. Gilbert, M. C. Gesnel, E. Houssaint & R. Breathnach: Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 6, 979-987 (1991)

34. Johnson, D. E., P. L. Lee, J. Lu & L. T. Williams: Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728-4736 (1990)

35. Avivi, A., A. Yayon & D. Givol: A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett. 330, 249-252 (1993)

36. Yan, G., Y. Fukabori, G. McBride, S. Nikolaropolous & W. L. McKeehan: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol. 13, 4513-4522 (1993)

37. Orr-Urtreger, A., M. T. Bedford, T. Burakova, E. Arman, Y. Zimmer, A. Yayon, D. Givol & P. Lonai: Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2. Dev. Biol. 158, 475-486 (1993)

38. Gilbert, E., F. Del Gatto, P. Champion-Arnaud, M.-C. Gesnel & R. Breathnach: Control of BEK and K-SAM Splice Sites in Alternative Splicing of the Fibroblast Growth Factor Receptor 2 Pre-mRNA. Mol. Cell. Biol. 13, 5461-5468 (1993)

39. Scotet, E. & E. Houssaint: The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific. Biochim. Biophys. Acta. 1264, 238-42 (1995)

40. Moscatelli, D.: High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell Physiol. 131, 123-130 (1987)

41. Chintala, S. K., R. R. Miller & C. A. McDevitt: Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Arch. Biochem. Biophys. 310, 180-186 (1994)

42. Chintala, S. K., R. R. Miller & C. A. McDevitt: Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes. Arch. Biochem. Biophys. 316, 227-234 (1995)

43. Olwin, B. & A. Rapraeger: Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118, 631-639 (1992)

44. Flaumenhaft, R., D. Moscatelli & D. B. Rifkin: Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol. 111, 1651-1659 (1990)

45. Ornitz, D. M. & P. Leder: Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267, 16305-16311 (1992)

46. Roghani, M., A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D. B. Rifkin & D. Moscatelli: Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269, 3976-3984 (1994)

47. Pantoliano, M. W., R. A. Horlick, B. A. Springer, D. E. Van Dyk, T. Tobery, D. R. Wetmore, J. D. Lear, A. T. Nahapetian, J. D. Bradley & W. P. Sisk: Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33, 10229-10248 (1994)

48. Bellus, G. A., I. McIntosh, E. A. Smith, A. S. Aylesworth, I. Kaitila, W. A. Horton, G. A. Greenhaw, J. T. Hecht & C. A. Francomano: A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10, 357-359 (1995)

49. Rousseau, F., J. Bonaventure, L. Legeal-Mallet, A. Pelet, J.-M. Rozet, P. Maroteaux, M. Le Merrer & A. Munnich: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371, 252-254 (1994)

50. Shiang, R., L. M. Thompson, Y.-Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur & J. J. Wasmuth: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78, 335-342 (1994)

51. Superti-Furga, A., G. Eich, H. U. Bucher, J. Wisser, A. Giedion, R. Gitzelmann & B. Steinmann: A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur. J. Pediatr. 154, 215-9 (1995)

52. Ikegawa, S., Y. Fukushima, M. Isomura, F. Takada & Y. Nakamura: Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum. Genet. 96, 309-11 (1995)

53. Tavormina, P. L., R. Shiang, L. M. Thompson, Y. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn & J. J. Wasmuth: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9, 321-328 (1995)

54. Rousseau, F., V. el Ghouzzi, A. L. Delezoide, L. Legeai-Mallet, M. Le Merrer, A. Munnich & J. Bonaventure: Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet. 5, 509-12 (1996)

55. Rousseau, F., P. Saugier, M. Le Merrer, A. Munnich, A.-L. Delezoide, P. Maroteaux, J. Bonaventure, F. Narcy & M. Sanak: Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat. Genet. 10, 11-12 (1995)

56. Tavormina, P. L., D. L. Rimoin, D. H. Cohn, Y. Z. Zhu, R. Shiang & J. J. Wasmuth: Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum. Mol. Genet. 4, 2175-7 (1995)

57. Reardon, W., R. M. Winter, P. Rutland, L. J. Pulleyn, B. M. Jones & S. Malcolm: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat. Genet. 8, 98-103 (1994)

58. Rutland, P., L. J. Pulleyn, W. Reardon, M. Baraitser, R. Hayward, B. Jones, S. Malcolm, R. M. Winter, M. Oldridge, S. F. Slaney, M. D. Poole & A. O. M. Wilkie: Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat. Genet. 9, 173-176 (1995)

59. Jabs, E. W., X. Li, A. F. Scott, G. Meyers, W. Chen, M. Eccles, J. Mao, L. R. Charnas, C. E. Jackson & M. Jaye: Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8, 275-279 (1994)

60. Meyers, G. A., D. Day, R. Goldberg, D. L. Daentl, K. A. Przylepa, L. J. Abrams, J. M. Graham, Jr., M. Feingold, J. B. Moeschler, E. Rawnsley, A. F. Scott & E. W. Jabs: FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J. Hum. Genet. 58, 491-8 (1996)

61. Oldridge, M., A. O. Wilkie, S. F. Slaney, M. D. Poole, L. J. Pulleyn, P. Rutland, A. D. Hockley, M. J. Wake, J. H. Goldin, R. M. Winter & et al.: Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum. Mol. Genet. 4, 1077-82 (1995)

62. Gorry, M. C., R. A. Preston, G. J. White, Y. Zhang, V. K. Singhal, H. W. Losken, M. G. Parker, N. A. Nwokoro, J. C. Post & G. D. Ehrlich: Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum. Mol. Genet. 4, 1387-90 (1995)

63. Park, W. J., G. A. Meyers, X. Li, C. Theda, D. Day, S. J. Orlow, M. C. Jones & E. W. Jabs: Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum. Mol. Genet. 4, 1229-33 (1995)

64. Schell, U., A. Hehr, G. J. Feldman, N. H. Robin, E. H. Zackai, C. de Die-Smulders, D. H. Viskochil, J. M. Stewart, G. Wolff, H. Ohashi, R. A. Price, J. Cohen, M.M. & M. Muenke: Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum. Mol. Genet. 4, 323-328 (1995)

65. Steinberger, D., J. B. Mulliken & U. Muller: Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum. Genet. 96, 113-5 (1995)

66. Meyers, G. A., S. J. Orlow, I. R. Munrow, K. A. Przylepa & E. W. Jabs: Fibroblast growth factor receptor 3 transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet. 11, 462-464 (1995)

67. Wilkie, A. O. M., G. M. Morriss-Kay, E. Y. Jones & J. K. Heath: Functions of fibroblast growth factors and their receptors. Current Biol. 5, 500-507 (1995)

68. Muenke, M., U. Schell, A. Hehr, N. H. Robin, H. W. Losken, A. Schinzel, L. J. Pulleyn, P. Rutland, W. Reardon, S. Malcolm & R. M. Winter: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8, 269-274 (1994)

69. Lajeunie, E., H. W. Ma, J. Bonaventure, A. Munnich & M. LeMerrer: FGFR2 mutations in Pfeiffer syndrome. Nat. Genet. 9, 108 (1995)

70. Przylepa, K. A., W. Paznekas, M. Zhang, M. Golabi, W. Bias, M. J. Bamshad, J. C. Carey, B. D. Hall, R. Stevenson, S. Orlow, M. M. Cohen, Jr. & E. W. Jabs: Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat. Genet. 13, 492-4 (1996)

71. Wilkie, A. O. M., S. F. Slaney, M. Oldridge, M. D. Poole, G. J. Ashworth, A. D. Hockley, R. D. Hayward, D. J. David, L. J. Pulleyn, P. Rutland, S. Malcolm, R. M. Winter & W. Reardon: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9, 165-172 (1995)

72. Bellus, G. A., K. Gaudenz, E. H. Zackai, L. A. Clarke, J. Szabo, C. A. Francomano & M. Muenke: Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 14, 174-6 (1996)

73. Stanescu, R., V. Stanescu & P. Maroteaux: Homozygous Achondroplasia: Morphologic and Biochemical Study of Cartilage. Am. J. Med. Genet. 37, 412-421 (1990)

74. Webster, M. K. & D. J. Donoghue: FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 13, 178-82 (1997)

75. Wilkie, A. O. M.: Craniosynostosis- genes and mechanisms. Hum. Mol. Genet. 6, 1647-1656 (1997)

76. Stephens, T. D. & T. R. McNulty: Evidence for a metameric pattern in the development of the chick humerus. J. Embryol. Exp. Morphol. 61, 191-205 (1981)

77. Cohn, M. J., J. C. Izpisúa-Belmonte, H. Abud, J. K. Heath & C. Tickle: Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell. 80, 739-746 (1995)

78. Crossley, P. H., G. Minowada, C. A. MacArthur & G. R. Martin: Roles for FGF8 in the induction, initiation, and maintenance of chick limb Development Cell. 84, 127-136 (1996)

79. Ohuchi, H., T. Nakagawa, A. Yamamoto, A. Araga, T. Ohata, Y. Ishimaru, H. Yoshioka, T. Kuwana, T. Nohno, M. Yamasaki, N. Itoh & S. Noji: The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development 124, 2235-44 (1997)

80. Vogel, A., C. Rodriguez & J. C. Izpisuabelmonte: Involvement Of Fgf-8 In Initiation, Outgrowth and Patterning Of the Vertebrate Limb. Development 122, 1737-1750 (1996)

81. Niswander, L. & G. R. Martin: FGF-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114, 755-768 (1992)

82. Suzuki, H. R., H. Sakamoto, T. Yoshida, T. Sugimura, M. Terada & M. Solursh: Localization of HstI transcripts to the apical ectodermal ridge in the mouse embryo. Dev. Biol. 150, 219-22 (1992)

83. Crossley, P. H. & G. R. Martin: The mouse FGF8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451 (1995)

84. Savage, M. P., C. E. Hart, B. B. Riley, J. Sasse, B. B. Olwin & J. F. Fallon: Distribution of FGF-2 suggests it has a role in chick limb bud growth. Dev. Dyn. 198, 159-70 (1993)

85. Summerbell, D.: A quantitative analysis of the effect of excision of the AER from the chick limb-bud. J. Embryol. Exp. Morphol. 32, 651-60 (1974)

86. Summerbell, D.: Interactions between the proximo-distal and antero-posterior coordinates of positional value during the specification of positional information in the early development of the chick limb bud. J. Embryol. Exp. Morphol. 32, 227-237 (1974)

87. Saunders, J. W.: The proximo-distal sequence of the origin of the parts of the chicken wing and the role of the ectoderm. J. Exp. Zool. 108, 363-404 (1948)

88. Niswander, L., C. Tickle, A. Vogel, I. Booth & G. R. Martin: FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell. 75, 579-587. (1993)

89. Fallon, J. F., A. Lopez, M. A. Ros, M. P. Savage, B. B. Olwin & B. K. Simandl: FGF-2: apical ectodermal ridge growth signal for chick limb Development Science 264, 104-7 (1994)

90. Riddle, R. D., R. L. Johnson, E. Laufer & C. Tabin: Sonic hedgehog mediates the polarizing activity of the ZPA. Cell. 75, 1401-16 (1993)

91. Chang, D. T., A. Lopez, D. P. von Kessler, C. Chiang, B. K. Simandl, R. Zhao, M. F. Seldin, J. F. Fallon & P. A. Beachy: Products, genetic linkage and limb patterning activity of a murine hedgehog gene. Development 120, 3339-53 (1994)

92. Niswander, L., S. Jeffrey, G. R. Martin & C. Tickle: A Positive Feedback Loop Coordinates Growth and Patterning in the Vertebrate Limb. Nature. 371, 609-612 (1994)

93. Laufer, E., C. E. Nelson, R. L. Johnson, B. A. Morgan & C. Tabin: Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell. 79, 993-1003 (1994)

94. Blunt, A. & D. Ornitz: (unpublished data)

95. Orr-Urtreger, A., D. Givol, A. Yayon, Y. Yarden & P. Lonai: Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419-1434 (1991)

96. Rossant, J., B. Cirna & J. Partanen: FGF signaling in mouse gastrulation and anterior-posterior patterning. Cold Spring Harb. Symp. on Quant. Biol. (in press)

97. Neilson, K. M. & R. E. Friesel: Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270, 26037-26040 (1995)

98. Vargesson, N., J. D. Clarke, K. Vincent, C. Coles, L. Wolpert & C. Tickle: Cell fate in the chick limb bud and relationship to gene expression. Development 124, 1909-18 (1997)

99. Kai Yu, W. Yuan, MC Naski, A. Chellaiah, DM Ornitz: Increase ligand binding affinity and receptor activity in fibroblast growth factor receptors containing mutations causing Alpert Syndrome (unpublished data)

100. Caplan, A. I. & D. G. Pechak. The cellular and molecular embryology of bone formation. In Bone and Mineral Research/5, Ed: W. A. Peck, vol. New York: Elsevier Science Publishers, New York, NY, 5, 117-183 (1987)

101. Kato, Y., M. Iwamoto & T. Koike: Fibroblast growth factor stimulates colony formation of differentiated chondrocytes in soft agar. J. Cell. Physiol. 133, 491-8 (1987)

102. Wroblewski, J. & C. Edwall-Arvidsson: Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner. Res. 10, 735-742 (1995)

103. Trippel, S. B., J. Wroblewsk, A.-M. Makower, M. C. Whelan, D. Schoenfeld & S. R. Doctrow: Regulation of growth-plate chondrocytes by insulin-like growth factor I and basic fibroblast growth factor. J. Bone Joint Surg. 75, 177-189 (1993)

104. Koike, T., M. Iwamoto, A. Shimazu, K. Nakashima, F. Suzuki & Y. Kato: Potent mitogenic effects of parathyroid hormone (PTH) on embryonic chick and rabbit chondrocytes. J. Clin. Invest. 85, 626-631 (1990)

105. Iwamoto, M., A. Shimazu, K. Nakashima, F. Suzuki & Y. Kato: Reduction of basic fibroblasts growth factor receptor is coupled with terminal differentiation of chondrocytes. J. Biol. Chem. 266, 461-467 (1991)

106. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo & P. Leder: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84, 911-921 (1996)

107. Peters, K., D. M. Ornitz, S. Werner & L. Williams: Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155, 423-430 (1993)

108. Shimazu, A., H. D. Nah, T. Kirsch, E. Koyama, J. L. Leatherman, E. B. Golden, R. A. Kosher & M. Pacifici: Syndecan-3 and the Control Of Chondrocyte Proliferation During Endochondral Ossification. Exp. Cell. Res. 229, 126-136 (1996)

109. Colvin, J. S., B. A. Bohne, G. W. Harding, D. G. McEwen & D. M. Ornitz: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397 (1996)

110. Su, W. C. S., M. Kitagawa, N. R. Xue, B. Xie, S. Garofalo, J. Cho, C. X. Deng, W. A. Horton & X. Y. Fu: Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 386, 288-292 (1997)

111. Coffin, J. D., R. Z. Florkiewicz, J. Neumann, T. Mort-Hopkins, G. W. Dorn II, P. Lightfoot, R. German, P. N. Howles, A. Kier, B. A. O'Toole, J. Sasse, A. M. Gonzalez, A. Baird & T. Doetschman: Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6, 1861-1873 (1995)

112. Twal, W. O., R. Vasilatos-Younken, C. V. Gay & J. Leach, R.M.: Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphyseal growth plate. J. Bone Miner. Res. 9, 1737-1744 (1994)

113. Zhou, M., R. L. Sutliff, R. J. Paul, J. N. Lorenz, J. B. Hoying, C. C. Haudenschild, M. Yin, D. Coffin, L. Kong, E. G. Kranias, W. Luo, G. P. Boivin, J. J. Duffy, S. S. Pawlowski & T. Doetschman: FGF2 Control of Vascular Tone. Nat. Genet. in press, (1998)

114. Naski, M. C., Q. Wang, J. Xu & D. M. Ornitz: Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233-237 (1996)

115. Webster, M. K. & D. J. Donoghue: Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520-527 (1996)

116. Webster, M. K., P. Y. D'Avis, S. C. Robertson & D. J. Donoghue: Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16, 4081-7 (1996)

117. Li, Y., K. Mangasarian, A. Mansukhani & C. Basilico: Activation of FGF receptors by mutations in the transmembrane domain. Oncogene 14, 1397-406 (1997)

118. Hanks, S. K., A. M. Quinn & T. Hunter: The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52 (1988)

119. Mohammadi, M., J. Schlessinger & S. R. Hubbard: Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86, 577-87 (1996)

120. Couly, G. F., P. M. Coltey & N. M. Le Douarin: the triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 117, 409-429 (1993)

121. Cohen, J., M.M.: Sutural biology and the correlates of craniosynostosis. Am. J. Med. Genetics. 47, 581-616 (1993)

122. Canalis, E. & L. G. Raisz: Effect of fibroblast growth factor on cultured fetal rat calvaria. Metabolism 29, 108-14 (1980)

123. McCarthy, T. L., M. Centrella & E. Canalis: Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 125, 2118-26 (1989)

124. Rodan, S. B., G. Wesolowski, K. Yoon & G. A. Rodan: Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 264, 19934-41 (1989)

125. Hurley, M. M., C. Abreu, J. R. Harrison, A. C. Lichtler, L. G. Raisz & B. E. Kream: Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268, 5588-93 (1993)

126. Hill, P. A., A. Tumber & M. C. Meikle: Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138, 3849-58 (1997)

127. Tang, K. T., C. Capparelli, J. L. Stein, G. S. Stein, J. B. Lian, A. C. Huber, L. E. Braverman & W. J. DeVito: Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes. J. Cell. Biochem. 61, 152-66 (1996)

128. Varghese, S., M. L. Ramsby, J. J. Jeffrey & E. Canalis: Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136, 2156-62 (1995)

129. Long, M. W., J. A. Robinson, E. A. Ashcraft & K. G. Mann: Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors [published erratum appears in J Clin Invest 1995 Nov;96(5):2541]. J. Clin. Invest. 95, 881-7 (1995)

130. Pitaru, S., S. Kotev-Emeth, D. Noff, S. Kaffuler & N. Savion: Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J. Bone Miner. Res. 8, 919-29 (1993)

131. Boudreaux, J. M. & D. A. Towler: Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J. Biol. Chem. 271, 7508-15 (1996)

132. Schedlich, L. J., J. L. Flanagan, L. A. Crofts, S. A. Gillies, D. Goldberg, N. A. Morrison & J. A. Eisman: Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor. J. Bone Miner. Res. 9, 143-52 (1994)

133. Levi, E., R. Fridman, H. Q. Miao, Y. S. Ma, A. Yayon & I. Vlodavsky: Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl. Acad. Sci. U.S.A. 93, 7069-7074 (1996)

134. Neilson, K. M. & R. Friesel: Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J. Biol. Chem. 271, 25049-57 (1996)

135. Iseki, S., A. O. M. Wilkie, J. K. Heath, T. Ishimaru, K. Eto & G. M. Morrisskay: Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied Fgf2. Development 124, 3375-3384 (1997)

136. Lomri, A., J. Lemonnier, C. de Pollack, M. Hott, N. de Parseval, E. Lajeunie, A. Munnich, D. Renier & P. J. Marie: Mutations in fibroblast growth factor receptor 2 in Apert syndrome promote fetal human calvaria cell differentiation and mesemchyme condensation. J. Bone Miner. Res. 12, S125 (1997)

137. Ueno, H., M. Gunn, K. Dell, A. Tseng, Jr. & L. Williams: A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem. 267, 1470-1476 (1992)